NUS and Harvard study: Lifestyle changes can cut cardiovascular disease risk by nearly 90% in women with gestational diabetes history
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 16-Dec-2025 18:11 ET (16-Dec-2025 23:11 GMT/UTC)
With cardiovascular disease and other chronic conditions like diabetes and obesity on the rise, NUS Medicine launches first of its kind Master of Science in Nutrition and Lifestyle Medicine to train more healthcare professionals in preventive medicine, focusing on lifestyle and nutrition to promote healthy ageing, lower healthcare costs, and support well-being across the lifespan.
A new study by investigators from Mass General Brigham aimed to understand if using a CPAP machine could also protect the heart and brain from cardiovascular events in people with OSA. Their findings, published in European Heart Journal, suggest that a more personalized approach for treating patients is needed—one that focuses on CPAP treatment for those who stand to gain the most, while exercising caution for those who may not benefit and could even be harmed.
A treatment commonly used for obstructive sleep apnoea (OSA), lowers the risk of serious cardiovascular events in some patients but not others, according to research published in the European Heart Journal today.
Our perception of time depends on heart rate—this is the conclusion reached by neuroscientists at HSE University. In their experiment, volunteers watched short videos designed to evoke specific emotions and estimated each video's duration, while researchers recorded their heart activity using ECG. The study found that the slower a participant's heart rate, the shorter they perceived the video to be—especially when watching unpleasant content. The study has been published in Frontiers in Psychology.
Trustworthy Artificial Intelligence for Personalised Risk Assessment, or AI4HF, is a 4-year project funded by the European Union’s Horizon Europe Framework
AI4HF aims to co-design, develop and evaluate the first trustworthy artificial intelligence (AI) tool for personalising the care and management of patients with heart failure.
The project brings together patients, clinicians and other stakeholders from Europe, South America and Africa with regular workshops to allow input from all
The workshops have produced many ideas for refining AI for heart failure treatment, including increasing health and digital literacy, personalised recommendations on improving lifestyle, and social components such as involvement of carers. A new round of workshops is ongoing
Regular walking is widely recognized for its significant benefits to overall health and well-being. Previous research has primarily focused on middle-to-high-income White populations. Now, a novel analysis using data from the Southern Community Cohort Study, involving 79,856 predominantly low-income and Black individuals across 12 southeastern US states, confirms the benefits of regular walking, especially at a faster pace, within a crucial, underrepresented group. The new study appearing in the American Journal of Preventive Medicine, published by Elsevier, underscores the importance of promoting walking, particularly at a brisk pace, as an effective form of physical activity for improving health.